Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...

University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

Mechanically retrieving a blood clot blocking a medium- or small-sized brain artery was no better at reducing disability 90 days after a stroke than standard care alone (including clot-busting ...

University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...

In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...

Treatment for those who have suffered a stroke due to a blood clot, which has been available in St. John’s since 2022, can ...

Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...

Surmodics, Inc. announced the early clinical use of its Pounce XL thrombectomy system, which is currently in limited market rel ...